Found 0 matching trials
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer NA Clinicians are currently proposing second-line hormonal treatment to a meta...
Show More Location
Institut de Cancerologie de l'Ouest
Learn More & Join Trial
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain N/A Lung cancer (LC) is the tumor responsible for the highest mortality worldwi...
Show More Learn More & Join Trial
Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY) PHASE1 To determine the recommended Phase IIa dose (RP2D) of the triplet combinati...
Show More Location
The University of Texas M. D. Anderson Cancer Center
Learn More & Join Trial
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma PHASE4 The purpose of this study is to determine whether the rituximab administrat...
Show More Location
Hospital Infanta Cristina
Learn More & Join Trial
Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence PHASE4 A randomized study to evaluate the safety and effects of transanal submucos...
Show More Location
Multiple Locations
Learn More & Join Trial
Masimo O3 Regional Oximetry Device in Pediatric Patients Undergoing Cardiac Surgery NA We evaluate the relationship between the regional tissue oxygenation value ...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Temozolomide in Treating Patients With Recurrent Oligodendroglial Tumors PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Kaiser Franz Josef Hospital
Learn More & Join Trial
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV) PHASE1 This is a multicenter, open-label, Phase 1b/2 efficacy and safety study of ...
Show More Location
Uniwersyteckie Centrum Kliniczne Klinika Onkoligii i Radioterapii
Learn More & Join Trial
Evaluation of the Efficiency of a Training Program Developed For Newly Graduate Nurses NA Brief Summary: This research is a randomized, pre-test post-test control gr...
Show More Location
Gazi University Nursing Faculty
Learn More & Join Trial
Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma PHASE2 This is an open-label, Phase II interventional study in order to assess eff...
Show More Location
University of Colorado Hospital
Learn More & Join Trial